Novavax plans flu/Covid vaccine trial in 2021

 

Hey well if I checked in with Stan eric the CEO of Novo ax as we are expecting the company's phase three results from the united states we've already seen some phase three results from the UK uh really any day now I asked him about the status of that he said they have accrued all of the events in the trial that they need to be able to assess the results and right now the data analysis is just happening here's what he said about the timing for when we might see those results.

 The public statement is that we'll have the data announced by the end of the second quarter I think it'll be sooner than that and so we're doing the statistics and you run the tables and and i think we'll be looking at data really soon data really soon coming from novovax on its vaccine now in terms of the timeline going forward from there they are hoping for authorizations really around the world potentially in the third a quarter now I asked him there is some thought that the FDA because we have three vaccines under emergency use authorization already may start asking companies that are still filing to pivot to full approval which he said he is not expecting they are still expecting to go the emergency use authorization route but if they did have to file a bla essentially a full approval of the application he said that wouldn't affect the timing of their filing but it could affect the timing of when the FDA actually acts on it now in terms of supply that's very important as well they've already manufactured 30 to 40 million doses.

 

 They have faced delays in manufacturing and shortages of raw materials he says by the end of this year they hope to be up to a manufacturing rate of 150 million to 200 million doses per month and next year 1.5 billion to two billion doses in the full year if they get everything onboard and all goes well guys now looking forward to the future as well we also talked about their plans in flu here's what uh snark said about that our the plan is to start a trial later this year of a combination vaccine we think that's going to be a really important product so that you get a seasonal flu and coronavirus vaccine shot every fall and then boosted every year and guys this is something that we've been hearing about from Pfizer and Moderna as well with the mRNA vaccines planning to start mrna flu trials potentially this year themselves but novavax already has phase three data in flu so this year they're planning to start the combo trial of flu and covet now that's going to be a long-term process this will just be a phase one trial but we're starting to see perhaps the next phase of these vaccines starting to play out guys but for the coronavirus vaccine itself this year in the US this one probably not going to see much demand yeah you have to wonder i mean you have half of the adults already vaccinated here in the US so we could be potentially talking booster shots as the role in the u.s for novavax if it gets cleared.